Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000266687 | SCV000329915 | pathogenic | not provided | 2021-11-22 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 23919265, 22473935, 31589614) |
Labcorp Genetics |
RCV001385846 | SCV001585840 | pathogenic | RYR1-related disorder | 2023-09-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser2270Leufs*13) in the RYR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RYR1 are known to be pathogenic (PMID: 23919265, 25960145, 28818389, 30611313). This variant is present in population databases (no rsID available, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with autosomal recessive RYR1-related myopathy (PMID: 22473935). ClinVar contains an entry for this variant (Variation ID: 280096). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000266687 | SCV002019928 | pathogenic | not provided | 2021-09-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002503974 | SCV002804750 | pathogenic | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV004546473 | SCV005042687 | pathogenic | Congenital multicore myopathy with external ophthalmoplegia | criteria provided, single submitter | clinical testing |